Literature DB >> 26622579

Hypoxia promotes C-X-C chemokine receptor type 4 expression through microRNA-150 in pancreatic cancer cells.

Jin-Shan Sun1, Xiao-Lan Zhang2, Yu-Jie Yang3, Zhan-Guo Nie1, Yong Zhang4.   

Abstract

Hypoxia promotes pancreatic cancer progression by triggering cancer cell invasion. However, the mechanism underlying this process remains unclear, hindering the development of effective therapies. The present study aimed to delineate the molecular mechanisms underlying the prometastatic effect of hypoxia in pancreatic cancer cells. The expression of microRNA-150 (miRNA-150) was detected using reverse transcription-quantitative polymerase chain reaction in pancreatic cancer samples and in the hypoxia-induced CaPan2 human pancreatic cancer cell line. The target gene was identified using bioinformatics and a luciferase reporter assay. Inhibition of the expression of C-X-C chemokine receptor type 4 (CXCR4) by miRNA-150 was confirmed using transfection with miRNA-150 mimics. The prometastatic effect of hypoxia was detected using migration assays. The expression of miRNA-150 was shown to be downregulated in pancreatic cancer samples compared with that in normal pancreatic tissue samples. Furthermore, its expression was reduced in hypoxia-induced CaPan2 cells, compared with that in control cells. Bioinformatics and the results of the luciferase reporter assay, demonstrated that miRNA-150 inhibited the expression of CXCR4 by directly targeting the 3' untranslated region of CXCR4 mRNA. The results of the migration assay showed that hypoxia promotes cell migration and invasion. However, this prometastatic effect was reversed by transfection with miRNA-150 mimics. The present results suggest that hypoxia promotes pancreatic cancer migration by downregulating miRNA-150.

Entities:  

Keywords:  C-X-C chemokine receptor type 4; hypoxia; miRNA-150; pancreatic cancer

Year:  2015        PMID: 26622579      PMCID: PMC4508976          DOI: 10.3892/ol.2015.3344

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  20 in total

1.  Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma.

Authors:  Qiao Ying; Linhui Liang; Weijie Guo; Ruopeng Zha; Qi Tian; Shenglin Huang; Jian Yao; Jie Ding; Meiyan Bao; Chao Ge; Ming Yao; Jinjun Li; Xianghuo He
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

2.  Stem-loop RT-qPCR for microRNA expression profiling.

Authors:  James Hurley; Doug Roberts; Andrew Bond; David Keys; Caifu Chen
Journal:  Methods Mol Biol       Date:  2012

Review 3.  Invited review: decoding the microRNA response to hypoxia.

Authors:  Roger Pocock
Journal:  Pflugers Arch       Date:  2011-01-05       Impact factor: 3.657

4.  The down-regulation of Notch1 inhibits the invasion and migration of hepatocellular carcinoma cells by inactivating the cyclooxygenase-2/Snail/E-cadherin pathway in vitro.

Authors:  Liang Zhou; De-Sheng Wang; Qing-Jun Li; Wei Sun; Yong Zhang; Ke-Feng Dou
Journal:  Dig Dis Sci       Date:  2012-10-07       Impact factor: 3.199

5.  Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α.

Authors:  Yoon Suk Oh; Ha Yon Kim; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim; Hyo Jin Lee
Journal:  Oncol Rep       Date:  2012-09-27       Impact factor: 3.906

6.  MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1.

Authors:  Mohit Sachdeva; Yin-Yuan Mo
Journal:  Cancer Res       Date:  2009-12-08       Impact factor: 12.701

7.  Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds.

Authors:  Sabyasachi Biswas; Sashwati Roy; Jaideep Banerjee; Syed-Rehan A Hussain; Savita Khanna; Guruguhan Meenakshisundaram; Periannan Kuppusamy; Avner Friedman; Chandan K Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

8.  miR-139 and miR-200c regulate pancreatic cancer endothelial cell migration and angiogenesis.

Authors:  Lei Li; Baiwen Li; Dafan Chen; Liyan Liu; Chen Huang; Zhanjun Lu; Lungen Lun; Xinjian Wan
Journal:  Oncol Rep       Date:  2015-05-04       Impact factor: 3.906

9.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

10.  Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease.

Authors:  Yi Zhang; Mingyu Fei; Geng Xue; Qi Zhou; Yin Jia; Li Li; Hong Xin; Shuhan Sun
Journal:  J Cell Mol Med       Date:  2012-02       Impact factor: 5.310

View more
  4 in total

Review 1.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

2.  Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer.

Authors:  Elizabeth C Little; Jennifer D Kubic; Ravi Salgia; Paul J Grippo; Deborah Lang
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

Review 3.  The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.

Authors:  Jan Korbecki; Klaudyna Kojder; Patrycja Kapczuk; Patrycja Kupnicka; Barbara Gawrońska-Szklarz; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

Review 4.  Targeting hypoxic tumor microenvironment in pancreatic cancer.

Authors:  Jinxin Tao; Gang Yang; Wenchuan Zhou; Jiangdong Qiu; Guangyu Chen; Wenhao Luo; Fangyu Zhao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  J Hematol Oncol       Date:  2021-01-13       Impact factor: 17.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.